# Aflac (AFL) Financial Model

Free Excel 3-statement financial model and company analysis for Aflac.

- Canonical: https://finamodel.com/companies/aflac
- Industry: Insurance
- Downloadable model: Yes
- Excel download: https://finamodel.com/company-models/AFL.xlsx

## Model Purpose

This model evaluates the equity valuation and statutory capital generation of Aflac Incorporated, focusing on the impact of USD/JPY exchange rate fluctuations, segment-level benefit ratios, and investment portfolio yields to determine the company's capacity for share repurchases and dividend growth.

## Company Overview

Aflac Incorporated is a leading provider of supplemental health and life insurance products, designed to pay cash benefits directly to policyholders for costs not covered by primary health insurance. The company operates a dual-engine business model, collecting recurring premiums and investing the float in a massive portfolio of fixed-income securities.
- **Business Segments**: Aflac Japan (~54% of total revenues), Aflac U.S. (~39% of total revenues), and Other/Corporate (~7%).
- **Key Geographies**: Japan and the United States.
- **Business Model Type**: Asset-heavy financial institution (insurance underwriter and investment manager).
- **Competitive Position**: The undisputed leader in cancer and medical insurance in Japan (in terms of policies in force) and the #1 provider of supplemental health insurance in the U.S.
- **Recent Major Events**: Transitioned to the Long-Duration Targeted Improvements (LDTI) accounting standard in 2023, which fundamentally changed the presentation of deferred profit liabilities and deferred acquisition costs. The company has also faced top-line headwinds in Japan due to limited-pay products reaching paid-up status.

## Revenue Deep Dive



### Aflac Japan

- **Segment Name**: Aflac Japan
- **Revenue Driver Formula**: (Policies in Force x Average Premium per Policy) + Net Investment Income + Realised Investment Gains/Losses
- **Historical Growth Rate**: -1% to -3% CAGR (in USD terms, heavily impacted by the weak Yen and paid-up policies).
- **Key Growth Levers and Headwinds**: Aging Japanese population driving demand for third-sector products (cancer, medical), offset by a weak Yen and legacy limited-pay life products reaching premium paid-up status (meaning no new premiums are collected, though coverage remains).
- **Pricing Dynamics**: Highly regulated, actuarially determined pricing based on morbidity and mortality tables.
- **Revenue Recognition Notes**: Premiums are recognised as earned over the premium-paying periods of the contracts.
- **Seasonality**: Generally stable, though Q1 often sees higher sales campaigns in Japan aligning with the corporate fiscal year.

### Aflac U.S.

- **Segment Name**: Aflac U.S.
- **Revenue Driver Formula**: (New Annualised Premium Sales + Renewal Premiums) + Net Investment Income
- **Historical Growth Rate**: 2% to 4% CAGR.
- **Key Growth Levers and Headwinds**: Penetration of the small business market, digital sales platforms, and expansion into dental/vision. Headwinds include employment levels and wage inflation affecting voluntary benefit uptake.
- **Pricing Dynamics**: Competitive voluntary benefits market; pricing is set at the employer group or individual level.
- **Revenue Recognition Notes**: Earned premiums recognised pro-rata over the policy period.
- **Seasonality**: Q4 is historically the strongest quarter for sales due to the U.S. open enrolment period.

## Cost Structure



### Variable Costs / COGS (Benefits and Claims)

- **Line-by-line breakdown**: Benefits and claims (payouts for cancer treatments, accidents, hospital stays), Reserve remeasurement gains/losses.
- **Gross Margin Range**: In insurance, this is viewed via the "Benefit Ratio" (Benefits / Net Earned Premiums). Aflac Japan typically runs a 60-63% benefit ratio; Aflac U.S. runs a 48-52% benefit ratio.
- **Key Input Costs**: Morbidity rates, healthcare inflation, and mortality rates.
- **Scaling**: Scales linearly with earned premiums, though frequency/severity of claims can cause quarterly volatility.

### Operating Expenses (Acquisition and Operating)

- **Amortisation of DAC**: Deferred Acquisition Costs (commissions and underwriting costs) amortised over the life of the policies.
- **Insurance Commissions**: Paid to agents, brokers, and corporate partners (e.g., Japan Post).
- **Insurance Expenses**: SG&A, headcount, IT infrastructure, and marketing.
- **Expense Ratios**: Aflac Japan targets an expense ratio of 20-23%. Aflac U.S. targets an expense ratio of 36-39%.

### Margin Profile

- **Pretax Margin**: Typically 20-25% on a consolidated basis.
- **Net Margin**: 18-22%, heavily skewed by realised investment gains/losses in any given year.
- **Margin Trend**: Stable operating margins, though reported GAAP margins fluctuate wildly based on derivative mark-to-market and FX translation.

## Balance Sheet Structure

- **Total Assets**: Approximately $130B - $150B.
- **Key Asset Categories**: Fixed maturity securities (corporate bonds, government bonds), Equity securities, Deferred Acquisition Costs (DAC).
- **Goodwill & Intangibles**: Minimal (less than 2% of assets), as Aflac is primarily an organic grower.
- **Working Capital Profile**: N/A for life/health insurance. The focus is on the investment portfolio duration matching the liability duration.
- **Liabilities**: Future policy benefits (reserves for future claims), Unpaid policy claims, Deferred profit liability (DPL).
- **PP&E**: Immaterial.

## Capital Expenditure & Investment

- **Capex as % of Revenue**: Less than 1% (primarily IT and digital platform investments).
- **Maintenance vs. Growth**: Almost entirely IT infrastructure and digital sales tools.
- **Investment Portfolio**: The true "capital allocation" engine. Aflac invests billions annually into fixed income, private credit, and middle-market loans to generate yield.
- **M&A Pattern**: Rare bolt-on acquisitions (e.g., Argus for dental/vision), but primarily an organic business.

## Debt & Capital Structure

- **Total Debt**: Approximately $7B - $8B.
- **Debt/Capitalisation Ratio**: Typically 20-25% (conservative for the sector).
- **Credit Rating**: A- to A+ range (S&P/Moody's).
- **Key Debt Instruments**: Yen-denominated senior notes (used as a natural hedge against the Japan business), USD senior notes.
- **Interest Rate Profile**: Largely fixed-rate debt to match long-duration assets.
- **Share Repurchase Programme**: Highly active. Aflac routinely repurchases $1B - $2B+ annually.
- **Dividend Policy**: Dividend Aristocrat with 40+ years of consecutive increases. Payout ratio is typically 25-30% of adjusted earnings.

## Cash Flow Characteristics

- **Operating Cash Flow**: $4B - $6B annually, driven by the massive float (premiums collected upfront, claims paid later).
- **Free Cash Flow**: For a life insurer, "Free Cash Flow" is best measured as Statutory Capital generated by the subsidiaries that can be dividended up to the holding company.
- **Major Non-Cash Items**: Amortisation of DAC, reserve remeasurements, unrealised FX translation losses, realised investment gains/losses.
- **Cash Tax Rate**: Typically 18-21%, benefiting from tax credits on certain investments.

## Sheet Structure

1. **Assumptions & Scenarios**: FX rates (USD/JPY), segment growth rates, benefit ratios, expense ratios, portfolio yields.
2. **Executive Summary**: Consolidated dashboard, adjusted EPS, ROE, and capital return metrics.
3. **Aflac Japan Segment**: JPY to USD translation, Net Earned Premiums, Net Investment Income, Benefits & Claims, Amortisation of DAC, Insurance Expenses, Pretax Income.
4. **Aflac U.S. Segment**: Net Earned Premiums, Net Investment Income, Benefits & Claims, Amortisation of DAC, Insurance Expenses, Pretax Income.
5. **Corporate & Other**: Corporate interest expense, net investment gains/losses, unallocated overhead.
6. **Consolidated Income Statement**: Aggregation of Japan, U.S., and Corporate.
7. **Investment Portfolio**: Roll-forward of fixed maturities, yield calculations, and net investment income generation.
8. **Consolidated Balance Sheet**: Investments, DAC, Future Policy Benefits, Debt, Shareholders' Equity (including AOCI).
9. **Capital Return & Share Count**: Dividend schedule, share repurchase schedule, basic and diluted shares outstanding.
10. **Valuation**: Dividend Discount Model (DDM) and Price/Adjusted Book Value multiple valuation.

## Key Financial Relationships

1. `Aflac Japan USD Revenue = Aflac Japan JPY Revenue / USD_JPY Average Exchange Rate`
2. `Segment Net Earned Premiums = Prior Year Net Earned Premiums * (1 + Premium Growth Rate)`
3. `Segment Benefits and Claims = Segment Net Earned Premiums * Segment Benefit Ratio`
4. `Segment Acquisition & Operating Expenses = Segment Total Revenue * Segment Expense Ratio`
5. `Segment Pretax Income = Segment Total Revenue - Segment Benefits and Claims - Segment Acquisition & Operating Expenses`
6. `Consolidated Net Investment Income = Average Investment Portfolio Balance * Blended Portfolio Yield`
7. `Adjusted Earnings = Consolidated Net Income - Realised Investment Gains/Losses - FX Translation Impacts`
8. `Adjusted EPS = Adjusted Earnings / Diluted Shares Outstanding`
9. `Ending Shares Outstanding = Beginning Shares Outstanding - (Share Repurchases / Average Share Price)`
10. `Dividends Paid = Annual Dividend Per Share * Shares Outstanding`

## Cross-Sheet Dependencies

- **Assumptions** dictates the USD/JPY exchange rate, which fundamentally drives the **Aflac Japan Segment** sheet.
- **Aflac Japan** and **Aflac U.S.** sheets feed directly into the **Consolidated Income Statement**.
- **Investment Portfolio** calculates Net Investment Income, which feeds into both Segment sheets (allocated) and the **Consolidated Income Statement**.
- **Consolidated Income Statement** generates Net Income, which feeds Retained Earnings on the **Consolidated Balance Sheet**.
- **Capital Return** calculates share repurchases, which reduces Cash on the **Balance Sheet** and reduces Share Count on the **Income Statement** (impacting EPS).

## Sign Convention

- **Revenues, Premiums, and Investment Income**: Positive.
- **Benefits, Claims, and Expenses**: Positive in their specific build-up schedules, but subtracted in the Income Statement to calculate Pretax Income.
- **Cash Flow**: Inflows are positive; outflows (dividends, share repurchases, debt paydown) are negative.
- **FX Translation**: A weaker Yen (higher USD/JPY ratio) results in a negative impact on USD-reported revenues.

## Things Most Likely to Go Wrong

- **FX Translation Errors**: The model must divide JPY figures by the USD/JPY rate, not multiply. Aflac Japan is ~54% of revenue; getting the FX math wrong will break the entire model.
- **GAAP vs. Adjusted Earnings**: Aflac reports massive swings in GAAP Net Income due to derivative mark-to-market and FX. The model must isolate "Adjusted Earnings" to calculate a meaningful P/E ratio.
- **LDTI Accounting Mismatch**: Pre-2023 historical data uses old DAC and reserve accounting. Do not attempt to trend pre-2023 margins directly into 2024/2025 without adjusting for LDTI.
- **Paid-Up Policies in Japan**: Aflac Japan's premium growth is negative because legacy policies are fully paid up. Do not model positive premium growth for Japan without a specific thesis on new product launches offsetting this structural headwind.
- **AOCI Volatility**: Accumulated Other Comprehensive Income (AOCI) swings wildly with interest rates. Valuation should be based on "Adjusted Book Value" (Book Value excluding AOCI).
- **Benefit Ratio Misallocation**: Do not use a consolidated benefit ratio. Japan and the U.S. have fundamentally different morbidity profiles and product mixes.

## Validation Checks

- "Aflac Japan Benefit Ratio must remain between 60.0% and 63.0%; flag if outside this range."
- "Aflac U.S. Benefit Ratio must remain between 48.0% and 52.0%; flag if outside this range."
- "Aflac Japan Expense Ratio must remain between 20.0% and 23.0%."
- "Aflac U.S. Expense Ratio must remain between 36.0% and 39.0%."
- "Total Assets must equal Total Liabilities + Shareholders' Equity in all periods."
- "Adjusted EPS growth should be positive despite flat revenue, driven by share repurchases."
- "Dividend payout ratio should not exceed 35% of Adjusted Earnings."

## Key Assumptions (Default Values)

| Assumption | Default Value | Unit | Rationale |
|---|---|---|---|
| USD/JPY Exchange Rate | 152.00 | Ratio | Blended average based on recent Q4 2024 / Q4 2025 actuals |
| Aflac Japan Premium Growth (JPY) | -1.5% | % | Reflects runoff of limited-pay products reaching paid-up status |
| Aflac U.S. Premium Growth | 3.5% | % | Reflects steady growth in small business and digital voluntary benefits |
| Aflac Japan Benefit Ratio | 61.5% | % | Midpoint of management's 60-63% target guidance |
| Aflac Japan Expense Ratio | 21.5% | % | Midpoint of management's 20-23% target guidance |
| Aflac U.S. Benefit Ratio | 50.0% | % | Midpoint of management's 48-52% target guidance |
| Aflac U.S. Expense Ratio | 37.5% | % | Midpoint of management's 36-39% target guidance |
| Investment Portfolio Yield | 4.5% | % | Blended yield on fixed maturities in current rate environment |
| Effective Tax Rate | 19.0% | % | Historical average, benefiting from specific investment tax credits |
| Annual Share Repurchases | 1,500 | $ Millions | Aligns with historical capital return run-rate |
| Dividend Per Share Growth | 5.0% | % | Consistent with Dividend Aristocrat track record |
| Cost of Equity (Ke) | 8.5% | % | Standard for large-cap, low-beta life insurers |

## Data Sources & Benchmarks

- **SEC EDGAR**: Aflac (AFL) 10-K and 10-Q filings.
- **Investor Relations**: Aflac's quarterly "Financial Supplement" is critical, as it provides the exact segment-level breakdown of premiums, NII, and ratios.
- **Key Peers**: Unum Group (UNM), Globe Life (GL), Prudential Financial (PRU), MetLife (MET).
- **Industry Data**: LIMRA (for U.S. supplemental health market share), Japan Ministry of Health, Labour and Welfare (for demographic and healthcare trends).

## Sources

- Aflac Incorporated 2024 and 2025 Form 10-K filings (SEC EDGAR).
- Aflac Q4 2024 and Q4 2025 Financial Supplements and Earnings Releases.
- Aflac 2025 Business & Sustainability Report.

---

## Frequently asked questions

### What kind of insurance products does Aflac offer?

Aflac Incorporated provides supplemental health and life insurance products to its policyholders. These products are designed to pay cash benefits directly to individuals for costs not covered by their primary health insurance plans.

### How does Aflac generate its revenue?

Aflac operates a dual-engine business model, primarily generating revenue from recurring premiums collected from its policyholders. The company also invests the substantial float from these premiums into a massive portfolio of fixed-income securities, which serves as another key revenue source.

### What are the key assumptions for Aflac's financial model regarding capital expenditures?

The financial model for Aflac incorporates a Capex_Pct_Revenue assumption of 0.03. These capital expenditures are primarily allocated to IT infrastructure and digital sales tools, reflecting the company's focus on technology investments.

### What factors are crucial for Aflac's equity valuation in the financial model?

The financial model for Aflac evaluates equity valuation by focusing on the impact of USD/JPY exchange rate fluctuations, segment-level benefit ratios, and investment portfolio yields. These factors are key to determining the company's capacity for share repurchases and dividend growth.

### Can I download an Excel financial model for Aflac?

Yes, a downloadable Excel financial model is available for Aflac. This model evaluates the company's equity valuation and statutory capital generation, with a forecast horizon extending from FY2026 to FY2030.

### What are Aflac's primary business segments and key geographies?

Aflac operates primarily through two major business segments: Aflac Japan, which accounts for approximately 54% of total revenues, and Aflac U.S., contributing about 39%. The company's key geographies are Japan and the United States, where it holds leading positions in supplemental insurance.

[Interactive forecast calculator](https://finamodel.com/companies/aflac/forecast)